HQL Short Volume
Tekla Life Sciences Investors (HQL) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $612.7M, listed on NYSE, carrying a beta of 0.71 to the broader market. Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. Led by Daniel R. Omstead, public since 1992-05-01.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-07-16
- Short Volume
- 32.2K
- Total Volume
- 77.4K
- Short %
- 41.56%
- 30-Day Avg Short %
- 40.33%
Showing 30 days of FINRA short volume data for Tekla Life Sciences Investors.
Learn how short volume is reported and how to read the data →
Frequently asked HQL short volume questions
- What is the daily HQL short volume?
- As of Jul 16, 2026, Tekla Life Sciences Investors (HQL) short volume is 32.2K shares against 77.4K total reported volume, or 41.56% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is HQL short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does HQL short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.